T1	Participants 430 540	double-blind, placebo-controlled trial of a single intravenous dose of synthetic human secretin in 60 children
T2	Participants 615 623	children
T3	Participants 1030 1067	60 children, 4 could not be evaluated
T4	Participants 1151 1162	56 children
T5	Participants 1339 1347	children
T6	Participants 1355 1369	secretin group
T7	Participants 1565 1578	placebo group
T8	Participants 1799 1807	children
T9	Participants 1663 1677	secretin group
T10	Participants 1694 1707	placebo group
T11	Participants 1900 1923	parents of the children
T12	Participants 2005 2013	children
